(Q37969219)

26 August 2017

title

Pharmacogenetics of obsessive-compulsive disorders (English)

1 reference

obsessive-compulsive disorder

26 August 2017

main subject

0 references

1

Eva J Brandl

1 reference

26 August 2017

Daniel J Müller

2

1 reference

26 August 2017

Margaret A Richter

series ordinal

3

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

13

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

71-81

1 reference

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

[Genetic findings in obsessive-compulsive disorder in childhood and adolescence and in adulthood].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Overview of genetics and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Obsessive and compulsive symptoms in a general population sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Evidence for a heritable unidimensional symptom factor underlying obsessionality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Symptom dimensions in OCD: item-level factor analysis and heritability estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A family study of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Genetics of obsessive-compulsive disorders: new findings and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The descriptive epidemiology of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Clinical practice. Obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A score for predicting response to pharmacotherapy in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A meta-analysis of functional neuroimaging in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Neuroimaging studies of obsessive-compulsive disorder in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Cerebral activation in children and adolescents with obsessive-compulsive disorder before and after treatment: a functional MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Effects of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

CYP2D6 in the brain: genotype effects on resting brain perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Obsessive-compulsive disorder and 5-HTTLPR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

5HT1Dbeta Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

HTR2A gene variation is involved in antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Genetic predictors of response to antidepressants in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Variant BDNF (Val66Met) impact on brain structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

A screen of SLC1A1 for OCD-related alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

No gene is an island: the flip-flop phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Obsessive-compulsive disorder phenotypes: implications for genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

The drug-naïve OCD patients imaging genetics, cognitive and treatment response study: methods and sample description.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Genome-wide association studies in pharmacogenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Is the 5-HT1DβReceptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Epileptiform Seizure After Sertraline Treatment in an Adolescent Experiencing Obsessive-Compulsive Disorder and Presenting a Rare Pharmacogenetic Status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.133

21 January 2018

Identifiers

DOI

10.2217/PGS.11.133

1 reference

26 August 2017

1 reference